<--- Back to Details
First PageDocument Content
Medicine / Immunosuppressants / Immunology / Clinical medicine / Monoclonal antibodies / Cytokines / Therapeutic antibodies / Autoimmune diseases / Infliximab / Anakinra / Adalimumab / Interferon
Date: 2015-08-17 11:45:03
Medicine
Immunosuppressants
Immunology
Clinical medicine
Monoclonal antibodies
Cytokines
Therapeutic antibodies
Autoimmune diseases
Infliximab
Anakinra
Adalimumab
Interferon

EAP Reimbursement Criteria for Frequently Requested Drugs

Add to Reading List

Source URL: www.health.gov.on.ca

Download Document from Source Website

File Size: 1,22 MB

Share Document on Facebook

Similar Documents

Neuroendocrinology Letters Volume 33 SupplComparison of gene expression of epicardial and visceral adipocytes with regard to the differentiation stage Institute for Clinical and Experimental Medicine, Departmen

DocID: 1vq9m - View Document

Policy Perspective - A Conversation with Peter Banys, MD, MSc Dr. Peter Banys is a Clinical Professor of Psychiatry at UCSF and Past-President of the California Society of Addiction Medicine. Over a three decade career h

DocID: 1vgR8 - View Document

Responsible Conduct of Research Data Susan Porter Clinical Associate Professor, Department of Pathology & Laboratory Medicine

DocID: 1vcR1 - View Document

1/3 2nd EurOPDX Workshop PDX models in clinical oncology and cancer precision medicine Seminar-Hotel Rigi am See

DocID: 1v75r - View Document

Centre for Cell Therapy and Regenerative Medicine 6th Margaret River Region Forum and 9th ASSCR Annual Scientific Meeting Stem Cells: Fundamental Biology and Clinical Translation

DocID: 1v4Rh - View Document